Flexible funds are essential for the development of new research infrastructures and will enable the CTH to respond to emerging and promising research areas in its strategic development towards a translational research center of excellence. In the final maturation and consolidation of the CTH following the interim review in 2017, the funds will primarily be used for specific projects and enabling technologies with a focus on innovative topics in the field of thrombosis and hemostasis. Scientists in the CTH and its supporting institutions can apply for these flexible funds to approach interdisciplinary projects between CTH Groups or with external collaborations. The program serves to stimulate high risk approaches, establishment of new disease models and research tools that will ultimately facilitate successful third party funding and promote the CTH nationally and internationally. Applications from CTH Junior Scientists are encouraged as an important component of the CTH career development concept. Flexible funds will also be important to provide adequate research support for new recruits of the CTH. The strategic development of the CTH not only depends on interactions within the UMC, but decisively on productive strategic alliances with national and international research centers and groups in the files. Funds for networking, visiting Professorships, and jointly organized meetings will be required to promote the CTH and its research program internationally.